Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
57 /100
HIGH RISK
Score updated Jul 25, 2026

ELOXD — Eloxx Pharmaceuticals, Inc. Dilution Risk Tracker

Track ELOXD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ELOXD — Get alerts when the score changes →

As of July 25, 2026, Eloxx Pharmaceuticals, Inc. (ELOXD) has a DilutionWatch DilutionScore of 57/100, rated HIGH dilution risk. Eloxx Pharmaceuticals, Inc. has 7.57M shares outstanding. Key dilution vectors include 323.9K outstanding warrants, approximately 4 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
85
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt—

Dilution Forecast

⛅
Watch
Minor dilution signals detected
17%
💰 Capital Raise 35%
• Low cash runway: 4 months remaining
🔔 Track ELOXD — Get forecast alerts →

Market Data

Market CapN/A
Shares Outstanding7.57M
FloatN/A
Cash$6.36M
DebtN/A
Short InterestN/A

Institutional Holdings

Institutional data not yet available.

Short Interest

Short interest data updating...

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2017-12-31
Full SEC filing analysis available with free account →

Recent News

No recent news

What This Means for ELOXD Shareholders

Eloxx Pharmaceuticals, Inc. (ELOXD) has a DilutionScore of 57/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 25, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 323,892 outstanding warrants for ELOXD. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: ELOXD has approximately 4 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ELOXD in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for ELOXD alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →

Understanding ELOXD's Dilution Risk Factors

Primary Risk Drivers

The most concerning factors for Eloxx Pharmaceuticals are Offering Ability and Cash Runway. Offering Ability scores at a level indicating significant potential for new equity issuance, which directly increases the company’s share count. Cash Runway is also highly elevated, signaling that the company has limited cash reserves—only 3.7 months remaining—which may force it to seek additional capital through dilutive means. This combination creates a critical risk environment where the firm might be compelled to issue new shares to fund operations, thereby reducing existing shareholders’ ownership stakes.

Factors Currently Not a Concern

Float Risk and Warrant Exposure are currently low, indicating minimal immediate impact from institutional or public float dilution and warrant conversions. However, any significant increase in outstanding warrants or changes in trading volume could elevate Float Risk. Similarly, if the company begins issuing convertible notes or enters into agreements that convert into equity, Convertible Note Risk would rise sharply. These factors remain benign unless specific actions or filings signal a shift in capital structure.

SEC Filings to Watch

Key SEC filings to monitor include S-3 registration statements, which may indicate plans for future equity offerings; 424B5 documents that often accompany shelf registrations and can signal upcoming capital raises; and 8-K Item 1.01 reports, which disclose material events such as new financing or strategic partnerships that could lead to dilution. Additionally, 10-Q quarterly reports will show cash position trends and may reveal signs of increasing financial strain, potentially triggering further dilutive actions.

How Dilution Happens

Dilution occurs when existing shareholders’ ownership percentage decreases due to new shares being issued. With Offering Ability at a high level, Eloxx could initiate equity offerings that directly increase the total share count. If Cash Runway remains low, this may prompt the company to issue more shares in exchange for capital. As these mechanisms activate, each new issuance reduces the value per existing share, thereby diluting current investors' stakes and potentially diminishing their returns.

What Would Make This Worse

A worsening scenario would unfold if ELOXD enters into multiple active dilution programs simultaneously, such as issuing convertible notes that convert into equity or launching new equity offerings under S-3 registrations. Additionally, a sharp decline in cash reserves coupled with an increase in Offering Ability or Convertible Note Risk could trigger a cascade of dilutive actions. Any major strategic partnership or funding round that includes equity issuance would also significantly escalate the risk profile.

Key Insight

Low scores are safer — interpret all risk factors inversely, with 0 representing no risk and 100 representing maximum risk.

How to Monitor ELOXD for Dilution Risk

What This Risk Level Means

A high dilution risk profile for Eloxx Pharmaceuticals indicates that the company is operating in a financially precarious position where its equity is under significant pressure. As an operating company, Eloxx’s reliance on external capital to fund operations places it in a vulnerable state. The elevated Offering Ability and Cash Runway scores suggest that the firm may be actively seeking new capital or already facing liquidity challenges. Given its size and operational focus, this level of dilution risk implies a potential need for frequent capital raises to sustain business activities, which increases exposure to shareholder dilution.

What Typically Happens Next

Companies with similar profiles often proceed through various financing mechanisms, including shelf registrations, ATM programs, or warrant exercises. These actions typically occur within 6–12 months of entering a high-dilution risk phase. The timing is often dictated by cash burn rates and upcoming milestones. For Eloxx, the presence of elevated convertible note risk suggests that future debt-to-equity conversions may be imminent, further increasing dilution pressure. Monitoring for such events is critical to understanding how quickly capital needs might escalate.

Monitoring Playbook

To effectively track Eloxx’s dilution risk, use DilutionWatch to set up alerts for changes in key scores and filings. Monitor the company at least monthly, focusing on SEC filings such as 8-Ks and S-1s. Set thresholds for Cash Runway above 80/100 and Offering Ability above 50/100 as early warning indicators. When these thresholds are crossed, review recent financing activities using Shelf & ATM Monitor to detect new equity offerings or warrant issuances.

Early Warning Signals

Three key signals to watch for include: 1) An increase in Offering Ability score above 60/100, indicating growing reliance on capital raising; 2) A drop in Cash Runway below 70/100, signaling potential liquidity issues; and 3) Filing of a new convertible note offering or warrant exercise announcement in SEC documents. These changes often precede further dilution events and should prompt immediate review.

What a Positive Resolution Looks Like

A positive shift in Eloxx’s profile would occur if the company secures a substantial capital raise, reducing its reliance on frequent equity issuance. Paying down convertible debt or allowing warrants to expire without exercise would also improve the risk score. Additionally, an improvement in Cash Runway above 70/100 and a reduction in Offering Ability below 40/100 would indicate a stabilization of financial health and reduced dilution exposure.

Watch For

Any sudden increase in Offering Ability or a drop in Cash Runway to 75/100 or lower, which may indicate an upcoming capital raise or liquidity crisis.

Full SEC filing analysis available with free account  →
Track ELOXD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ELOXD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ELOXD
ELOXD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.